Phytochemical Name : Quercetin-3-methyl ether

Properties Information
PhytoCAT-ID PhytoCAT-172
Phytochemical name or plant extracts Quercetin-3-methyl ether
PMID 22086611
Literature evidence Overall, these results suggested that quercetin-3-methyl ether might be a novel and promising therapeutic agent in lapatinib-sensitive or -resistant breast cancer patients.
IUPAC name 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxychromen-4-one
Phytochemicals’ class or type of plant extracts Flavonoid
Source of phytochemicals or plant Extracts Wollastonia biflora
Geographical availability Andaman Is., Assam, Bangladesh, Bismarck Archipelago, Cambodia, Caroline Is., Chagos Archipelago, China South-Central, China Southeast, Christmas I., Cocos (Keeling) Is., Comoros, Cook Is., Fiji, Gilbert Is., Hainan, India, Jawa, Kazan-retto, KwaZulu-Natal, Laos, Malaya, Maldives, Marianas, Marshall Is., Mozambique, Mozambique Channel I, Myanmar, Nansei-shoto, New Caledonia, New South Wales, Nicobar Is., Niue, Norfolk Is., Northern Territory, Ogasawara-shoto, Philippines, Queensland, Samoa, South China Sea, Sri Lanka, Taiwan, Thailand, Tibet, Tonga, Tubuai Is., Tuvalu, Vanuatu, Vietnam, Wallis-Futuna Is.
Plant parts NA
Other cancers Breast cancer
Target gene or protein Caspase 3, Caspase 7, PARP
Gene or Protein evidence Moreover, quercetin-3-methyl ether induced significant apoptosis, accompanied with increased levels of cleaved caspase 3, caspase 7, and poly(ADP-ribose) polymerase (PARP) in both cell lines.
Target pathways Chk1-Cdc25c-cyclin B1/Cdk1 pathway
IC50 NA
Potency Overall, these results suggested that quercetin-3-methyl ether might be a novel and promising therapeutic agent in lapatinib-sensitive or -resistant breast cancer patients.
Cell line/ mice model SKBR-3
Additional information  NA
PubChem ID 5280681
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:260687-1
Safety NA